Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Puhr

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Molecular and Cellular Endocrinology|June 14, 2011
Interleukin-6: a multifunctional targetable cytokine in human prostate cancerZoran Culig, Martin Puhr
Molecular and Cellular Endocrinology|March 20, 2017
Interleukin-6 and prostate cancer: Current developments and unsolved questionsZoran Culig, Martin Puhr
The American Journal of Pathology|December 17, 2023
Androgen Receptor-Interacting Proteins in Prostate Cancer Development and Therapy ResistanceZoran Culig, Martin Puhr
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 31, 2012
SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent mannerHannes Neuwirt, Iris E Eder, Martin Puhr, et al.
The Prostate|July 30, 2008
Oligomeric proanthocyanidin complexes (OPC) exert anti-proliferative and pro-apoptotic effects on prostate cancer cellsHannes Neuwirt, Mercedes Cedeno Arias, Martin Puhr, et al.
Endocrine-Related Cancer|March 1, 2013
In vitro model systems to study androgen receptor signaling in prostate cancerNatalie Sampson, Hannes Neuwirt, Martin Puhr, et al.
Endocrine-Related Cancer|March 26, 2010
SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signallingMartin Puhr, Frédéric R Santer, Hannes Neuwirt, et al.
Endocrine-Related Cancer|November 30, 2007
Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretionHannes Neuwirt, Martin Puhr, Ilaria T Cavarretta, et al.
International Journal of Cancer|February 15, 2018
Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactionsNatalie Sampson, Elena Brunner, Anja Weber, et al.
Journal of Cancer Research and Clinical Oncology|September 23, 2022
Metabolic changes during prostate cancer development and progressionAlicia-Marie K Beier, Martin Puhr, Matthias B Stope, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Molecular and Cellular Endocrinology|June 14, 2011
Interleukin-6: a multifunctional targetable cytokine in human prostate cancerZoran Culig, Martin Puhr
Molecular and Cellular Endocrinology|March 20, 2017
Interleukin-6 and prostate cancer: Current developments and unsolved questionsZoran Culig, Martin Puhr
The American Journal of Pathology|December 17, 2023
Androgen Receptor-Interacting Proteins in Prostate Cancer Development and Therapy ResistanceZoran Culig, Martin Puhr
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 31, 2012
SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent mannerHannes Neuwirt, Iris E Eder, Martin Puhr, et al.
The Prostate|July 30, 2008
Oligomeric proanthocyanidin complexes (OPC) exert anti-proliferative and pro-apoptotic effects on prostate cancer cellsHannes Neuwirt, Mercedes Cedeno Arias, Martin Puhr, et al.
Endocrine-Related Cancer|March 1, 2013
In vitro model systems to study androgen receptor signaling in prostate cancerNatalie Sampson, Hannes Neuwirt, Martin Puhr, et al.
Endocrine-Related Cancer|March 26, 2010
SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signallingMartin Puhr, Frédéric R Santer, Hannes Neuwirt, et al.
Endocrine-Related Cancer|November 30, 2007
Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretionHannes Neuwirt, Martin Puhr, Ilaria T Cavarretta, et al.
International Journal of Cancer|February 15, 2018
Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactionsNatalie Sampson, Elena Brunner, Anja Weber, et al.
Journal of Cancer Research and Clinical Oncology|September 23, 2022
Metabolic changes during prostate cancer development and progressionAlicia-Marie K Beier, Martin Puhr, Matthias B Stope, et al.
Pageof 7